On Thursday, KeyBanc Capital Markets maintained its Overweight rating on Synopsys, Inc. (NASDAQ:SNPS), with a steady price target of $690.00. The firm highlighted Synopsys's modest fourth-quarter earnings beat and a quarter-over-quarter increase in backlog, which now stands at $8.1 billion.
According to InvestingPro data, the company maintains impressive gross profit margins of 80.5%, while nine analysts have recently revised their earnings expectations upward for the upcoming period. Despite the positive results, Synopsys has adopted a cautious outlook for fiscal year 2025, projecting revenue growth of approximately 10.6%, which is below the consensus expectations.
The company's guidance takes into account several factors, including an extra week in fiscal year 2024, a change in the fiscal year-end, cautiousness regarding its China business, and the recent acquisition of ANSS. KeyBanc noted that excluding the mechanical factors, the revenue growth guidance would have been closer to 12%. The firm remains confident in the long-term opportunities for Synopsys, particularly in areas such as 3D-IC and artificial intelligence (AI).
KeyBanc expressed belief in the enduring tailwinds for electronic design automation (EDA) and the potential for Synopsys to surpass its conservative fiscal year 2025 outlook. The firm's stance suggests that the current guidance may be understated, potentially setting up for future upside surprises.
With a market capitalization of $90.32 billion and strong revenue growth of 26.26% over the last twelve months, InvestingPro analysis indicates the stock is currently trading above its Fair Value. Subscribers can access 18 additional ProTips and comprehensive valuation metrics on the platform. Synopsys's approach for the upcoming fiscal year has been described as "pragmatic," reflecting a blend of caution and realistic expectations amid various influencing factors.
Synopsys's performance and future prospects remain a focus for investors, as the company navigates through the complexities of the global tech landscape. The reaffirmation of the Overweight rating and price target indicates a continued positive outlook from KeyBanc despite the conservative revenue growth forecast for fiscal year 2025.
InvestingPro's Financial Health Score rates Synopsys as "GREAT" with a score of 3.04, reflecting strong fundamentals. For detailed insights, investors can access the comprehensive Pro Research Report, available exclusively to subscribers.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.